Risperdal Marketing Blocks Weren't For Kids, Pa. Jury Told

Law360, Philadelphia (October 3, 2019, 7:14 PM EDT) -- A Philadelphia trial over a Johnson & Johnson unit’s allegedly reckless conduct in pushing the antipsychotic medication Risperdal for use in adolescents devolved into playtime on Thursday as a company witness disputed that blocks emblazoned with the drug’s name were created as children’s toys to market the drug to pediatricians.

Smiling as he slowly stacked a set of the four soft Lego-like blocks on the front wall of a jury box in Philadelphia, Thomas Kline, an attorney with Kline & Specter PC representing a Maryland man who grew breasts after taking the powerful antipsychotic medication as a child, pressed a Janssen...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS